Discovery
Clinical Pharmacology & Therapeutics (2009); 85, 2, 204–207 doi:10.1038/clpt.2008.246
Phase 0 Clinical Studies in Oncology
JM Collins1
1Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, Rockville, Maryland, USA
Correspondence: JM Collins, (collinsje@mail.nih.gov)
Received 16 September 2008; Accepted 27 October 2008; Published online 24 December 2008.
